The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
C-Reactive Protein Levels in Schizophrenia: A Review and Meta-Analysis
Abstract
There is an impression in the literature that schizophrenia is associated with increased inflammation, including abnormal blood levels of the acute phase reactant C-reactive protein (CRP). We performed a meta-analysis of blood CRP levels to estimate the overall effect size, as well as a pooled analysis of the prevalence of an elevated CRP level in patients with schizophrenia and related disorders. We identified articles by searching PubMed, PsycInfo, and ISI, and the reference lists of identified studies. Eight studies met the inclusion criteria for the meta-analysis, and five studies were included in the pooled analysis. CRP levels were significantly increased in patients compared to controls (effect size=0.45, 95% confidence interval 0.34-0.55, p<0.001). There was a 28% prevalence of an elevated CRP level in patients with schizophrenia and related disorders. Our results support a growing body of literature that schizophrenia is associated with increased inflammation, although many studies did not control for potential confounding factors such as BMI and smoking. Given the high prevalence of elevated CRP, metabolic syndrome, and premature cardiovascular mortality, our findings also suggest that measurement of blood CRP levels may be germane to the clinical care of patients with schizophrenia and related disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Self-citationMetabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis
Galassi, A., Reynolds, K., & He, J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.031 · Cited by 1,207
McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., Meltzer, H. Y., Hsiao, J., Scott Stroup, T., & Lieberman, J. A. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,140
Hunter, J. E., & Schmidt, F. L. (2000) · International Journal of Selection and Assessment · doi:10.1111/1468-2389.00156 · Cited by 833
Cytokines and schizophrenia: microglia hypothesis of schizophrenia
Monji, A., Kato, T., & Kanba, S. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01945.x · Cited by 508
O’Connor, M.-F., Bower, J. E., Cho, H. J., Creswell, J. D., Dimitrov, S., Hamby, M. E., Hoyt, M. A., Martin, J. L., Robles, T. F., Sloan, E. K., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.04.005 · Cited by 500
Müller, N., Riedel, M., Scheppach, C., Brandstätter, B., Sokullu, S., Krampe, K., Ulmschneider, M., Engel, R. R., Möller, H.-J., & Schwarz, M. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1029 · Cited by 388
Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs
Maes, M., Delange, J., Ranjan, R., Meltzer, H. Y., Desnyder, R., Cooremans, W., & Scharpé, S. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(96)02915-0 · Cited by 341
AKHONDZADEH, S., TABATABAEE, M., AMINI, H., AHMADIABHARI, S., ABBASI, S., & BEHNAM, B. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.016 · Cited by 289
Laan, W., Grobbee, D. E., Selten, J.-P., Heijnen, C. J., Kahn, R. S., & Burger, H. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05117yel · Cited by 264
Müller, N., Krause, D., Dehning, S., Musil, R., Schennach-Wolff, R., Obermeier, M., Möller, H.-J., Klauss, V., Schwarz, M. J., & Riedel, M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.04.015 · Cited by 250
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
Fernandez-Egea, E., Bernardo, M., Donner, T., Conget, I., Parellada, E., Justicia, A., Esmatjes, E., Garcia-Rizo, C., & Kirkpatrick, B. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.052605 · Cited by 242
The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence
Smith, R. S., & Maes, M. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90062-4 · Cited by 224
Dickerson, F., Stallings, C., Origoni, A., Boronow, J., & Yolken, R. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.022 · Cited by 205
Hope, S., Melle, I. S., Aukrust, P., Steen, N. E., Birkenaes, A. B., Lorentzen, S., Agartz, I., Ueland, T., & Andreassen, O. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00757.x · Cited by 171
C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians
Windgassen, E. B., Funtowicz, L., Lunsford, T. N., Harris, L. A., & Mulvagh, S. L. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.01.2252 · Cited by 170
Fan, X., Pristach, C., Liu, E. Y., Freudenreich, O., Henderson, D. C., & Goff, D. C. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.07.011 · Cited by 159
M�ller, N., Ulmschneider, M., Scheppach, C., Schwarz, M., Ackenheil, M., M�ller, H.-J., Gruber, R., & Riedel, M. J. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0478-1 · Cited by 156
Schwarz, M., Müller, N., Riedel, M. J., & Ackenheil, M. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1203 · Cited by 153
Baptista, T., Rangel, N., Fernández, V., Carrizo, E., Fakih, Y. E., Uzcátegui, E., Galeazzi, T., Gutiérrez, M. A. M., Servigna, M., Dávila, A., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.029 · Cited by 144
Endogenous Retrovirus Type W GAG and Envelope Protein Antigenemia in Serum of Schizophrenic Patients
Perron, H., Mékaoui, L., Bernard, C., Veas, F., Stefas, I., & Leboyer, M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.028 · Cited by 137
Meyer, J. M., McEvoy, J. P., Davis, V. G., GOFF, D. C., Nasrallah, H. A., Thomas, S., Hsiao, J., Swartz, M. S., Stroup, T. S., & Lieberman, J. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.005 · Cited by 113
Altered Levels of Acute Phase Proteins in the Plasma of Patients with Schizophrenia
Yang, Y., Wan, C., Li, H., Zhu, H., La, Y., Xi, Z., Chen, Y., Jiang, L., Feng, G., & He, L. (2006) · Analytical Chemistry · doi:10.1021/ac051916x · Cited by 103
Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients
Henderson, D. C., Fan, X., Copeland, P. M., Sharma, B., Borba, C. P. C., Boxill, R., Freudenreich, O., Cather, C., Evins, A. E., & GOFF, D. C. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819a8dbe · Cited by 102
C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia
Fawzi, M. H., Fawzi, M. M., Fawzi, M. M., & Said, N. S. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.05.010 · Cited by 97
Carrizo, E., Fernández, V., Quintero, J., Connell, L., Rodríguez, Z., Mosquera, M., Acosta, A., & Baptista, T. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.03.004 · Cited by 88
Akanji, A. O., OHAERI, J. U., Al-Shammri, S., & Fatania, H. R. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.010 · Cited by 68
Wan, C., La, Y., Zhu, H., Yang, Y., Jiang, L., Chen, Y., Feng, G., Li, H., Sang, H., Hao, X., et al. (2006) · Amino Acids · doi:10.1007/s00726-005-0292-8 · Cited by 61
Nunes, S. O. V., Matsuo, T., Kaminami, M. S., Watanabe, M. A. E., Reiche, E. M. V., & Itano, E. N. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.02.003 · Cited by 50
Löffler, S., Löffler-Ensgraber, M., Fehsel, K., & Klimke, A. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833643fd · Cited by 46
Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16
Maes, M. H. J., Delanghe, J., Bocchio‐Chiavetto, L., Bignotti, S., Tura, G. B., Pioli, R., Zanardini, R., & Altamura, C. A. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00298-0 · Cited by 44
Валентиновна, Щ. И., Neshkova, E. A., Dotsenko, V., Platonova, T., Щербакова, Е. Н., & Yarovaya, G. A. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00099-5 · Cited by 43
Sarandöl, A., Kırlı, S., Akkaya, C., Ocak, N., Eröz, E., & Sarandöl, E. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077609 · Cited by 42
Müller, N. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220802507852 · Cited by 42
Baptista, T., Dávila, A., Fakih, Y. E., Uzcátegui, E., Rangel, N., Olivares, Y., Galeazzi, T., Vargas, D., Peña, R., Marquina, D., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328080ca44 · Cited by 42
Vuksan‐Ćusa, B., Šagud, M., & Jakovljević, M. (2010) · PubMed · Cited by 38
Possible effects of some antipsychotic drugs on C-reactive protein in a drug-naïve psychotic sample
DÍAZ, F. J., Pérez‐Iglesias, R., Mata, I. F., Martínez‐García, O., Vázquez‐Barquero, J. L., de León, J., & Crespo‐Facorro, B. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.06.002 · Cited by 37
Baptista, T., Sandia, I., Lacruz, A., Rangel, N., Mendoza, S., Beaulieu, S., Contreras, Q., Galeazzi, T., & Vargas, D. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32801182e6 · Cited by 36
Mazzarello, V., Cecchini, A., Fenu, G., Rassu, M., Dessy, L. A., Lorettu, L., & Montella, A. (2004) · PubMed · Cited by 31
Osteoprotegerin levels in patients with severe mental disorders
Hope, S., Melle, I. S., Aukrust, P., Agartz, I., Lorentzen, S., Steen, N. E., Djurovic, S., Ueland, T., & Andreassen, O. A. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090088 · Cited by 25
Severance, E. G., Dickerson, F., Stallings, C. R., Origoni, A. E., Sullens, A., Monson, E. T., & Yolken, R. H. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0164-y · Cited by 17
Kim, S. H., Reaven, G. M., & Lindley, S. E. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283400cd3 · Cited by 13
Zakharyan, R., Chavushyan, A., Khoyetsyan, A., Stahelova, A., Arakelyan, A., Boyajyan, A. S., Mrázek, F., & Petřek, M. (2010) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2010.00942.x · Cited by 7
Cited by
Inflammation and Schizophrenia
Kirkpatrick, B., & Miller, B. J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt141 · Cited by 312
Self-citationInflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study
Hartwig, F. P., Borges, M. C., Horta, B. L., Bowden, J., & Davey Smith, G. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3191 · Cited by 302
Henderson, D. C., Vincenzi, B., Andrea, N. V., Ulloa, M., & Copeland, P. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00115-7 · Cited by 288
Costello, H., Gould, R. L., Abrol, E., & Howard, R. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027925 · Cited by 248
Prins, B. P., Abbasi, A., Wong, A., Vaez, A., Nolte, I., Franceschini, N., Stuart, P. E., Guterriez Achury, J., Mistry, V., Bradfield, J. P., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001976 · Cited by 199
“In contrast, others have previously shown that CRP levels are significantly elevated in patients with schizophrenia [69,70], with a recent meta-analysis concluding Effect size (95% CI) per 1-mg/l increase in lnCRP.”
Result
Metadata
- Authors
- Miller, B. J., Culpepper, N., & Rapaport, M. H.
- Venue
- Clinical Schizophrenia & Related Psychoses
- Publisher
- Longdom Group
- Published
- 2014-01
- Volume
- 7
- Issue
- 4
- Pages
- 223-230
- ISSN
- 1935-1232 (ISSN-L)
- OpenAlex
- W2179568988
- Cited by
- 267
- References
- 48
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.